PHIA Koninklijke Philips N.V.

Philips highlights FetView cloud-based image sharing and reporting software for obstetrics and gynecology at ISUOG 2022

Philips highlights FetView cloud-based image sharing and reporting software for obstetrics and gynecology at ISUOG 2022

September 15, 2022

Philips FetView will offer real-time, off cart remote patient management with access to data from any ultrasound system, anytime and anywhere, to enhance diagnostic confidence for physicians and provide peace of mind for expectant mothers

Amsterdam, the Netherlands and London, United Kingdom – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the upcoming addition of  the FetView cloud-based fetal ultrasound image sharing and reporting software for obstetrics/gynecology (OB/GYN). As a vendor-neutral cloud-based platform for ultrasound images, FetView will utilize the ultrasound image data to convey fetal growth projections and provide a user-friendly platform for physician to physician and physician to patient communication.

Philips Fetview is an integrated solution that combines fetal ultrasound imaging with enhanced reporting and easy access to an expectant mother’s medical data and fetal images. All results are securely stored and displayed in real time. With this upcoming addition of FetView into Philips’ advanced portfolio for – which includes Handheld Ultrasound, diagnostic ultrasound systems , and mobile app – pregnant women and their care teams will have access to a comprehensive overview of how a pregnancy is progressing to help provide peace of mind to patients and enhance diagnostic confidence for clinicians.

With OB/GYN ultrasounds performed in different clinical settings, immediate remote access to ultrasound images and medical histories for collaborative decision-making and easy sharing of images with patients is a challenge. Philips FetView will allow physicians to view, analyze, and annotate ultrasound images in real time via a cloud-based browser-accessible platform for secure image sharing, to help improve quality access to care, reduce patient mobility in case of high-risk pregnancies or post-surgery conditions, and reduce the need to rescan patients. By enabling full digitalization of OB/GYN workflows and patient management, Philips FetView will help drive greater departmental efficiency, reduce costs, and provide a better patient and staff experience.

“I see multiple patients from many areas in my daily practice, and the implementation of FetView has meant a turbo boost in productivity for my practice,” said Prof. Alexander Scharf,  Managing Director, MVZ PraenatGyn, Mainz, Germany. “The flexibility of the software is seamlessly integrated into my existing workflows and everything I need to access in the reporting is just one click away. FetView has also had a very positive impact on my patients, who have showed great enthusiasm for this program. The digital sharing of ultrasound images taken as part of prenatal care in accordance with data protection regulations and shared via a secure portal, help provide added peace of mind which is so important to expectant mothers.”

“The cloud-based reporting and image sharing capabilities of Philips FetView enhance remote communication between physicians and patients,” said Matthijs Groot Wassink, General Manger, OB/GYN Ultrasound at Philips. “By digitizing the workflow, we are taking ultrasound to the next level, delivering smart ultrasound documentation to any OB/GYN practice. The digital reporting and image sharing, and fully customizable design are hugely helpful for physicians, helping to drive efficiency and cost savings with increasing patient satisfaction in their daily practice.”

Philips FetView’s vendor-neutral software will retrieve images and measurement data via a secure encrypted DICOM interface and display them in a structured layout where care team members can easily add new information and data in line with their individual specialisms and produce easy-to-read growth curves. The application also streamlines the generation of reports in PDF format to be uploaded to electronic patient records and shared online with other clinicians and individual patients.

Philips FetView will be featured with additional helping to drive earlier and more definitive diagnoses being showcased at this year’s International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) World Congress (September 16 – 18, 2022, London, U.K.). Philips is also hosting a Satellite Symposium [1] on September 16 at ISUOG 2022 (Hall 3, 12:30 – 13:30 BST), where international thought leaders, including Prof. Scharf, will discuss the future of obstetric and gynecological care and fetal medicine.

[1] Available for 12 months after the event on the

For further information, please contact:

Kathy O’Reilly

Philips Global Press Office

Tel.:

E-mail :

Twitter:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 79,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
15/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

 PRESS RELEASE

Philips expands commercial availability of world’s first real-time AI-...

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA – (NYSE: PHG, AEX: PH...

 PRESS RELEASE

Philips launches Verida, world’s first detector-based spectral CT powe...

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, (NYSE: PHG, AEX: PHIA), a global leader in health techno...

 PRESS RELEASE

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MR...

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at . A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch